SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001396814-21-000037
Filing Date
2021-06-08
Accepted
2021-06-08 08:01:30
Documents
14
Period of Report
2021-06-08
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K pcrx-20210608.htm   iXBRL 8-K 33375
2 EX-99.1 pcrx-may2021revenuepressre.htm EX-99.1 20597
6 PACIRA BIOSCIENCES LOGO pacirabiosciencesa01.jpg GRAPHIC 27796
  Complete submission text file 0001396814-21-000037.txt   236375

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT pcrx-20210608.xsd EX-101.SCH 1921
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT pcrx-20210608_lab.xml EX-101.LAB 24270
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT pcrx-20210608_pre.xml EX-101.PRE 12654
7 EXTRACTED XBRL INSTANCE DOCUMENT pcrx-20210608_htm.xml XML 11027
Mailing Address 5 SYLVAN WAY SUITE 300 PARSIPPANY NJ 07054
Business Address 5 SYLVAN WAY SUITE 300 PARSIPPANY NJ 07054 973-254-3560
Pacira BioSciences, Inc. (Filer) CIK: 0001396814 (see all company filings)

IRS No.: 510619477 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35060 | Film No.: 211001279
SIC: 2834 Pharmaceutical Preparations